Hikal schedules Q2 and H1 FY27 earnings conference call

Board & Shareholder Meetings View source PDF Explain this filing

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹193.27

prior close

₹193.27

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+3.2% vs market

Pharmaceuticals peers, median of 173sector+2.0%+3.0% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+1.6

15m

+2.2

30m

+2.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9+1.7+3.2+2.0+3.0

Next day

+4.6pendingpending+2.6+2.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hikal will hold an earnings conference call on November 3, 2026 at 5:00 PM IST to discuss financial and operational performance for the quarter and half year ended September 30, 2026. Chairman and Managing Director Sameer Hiremath, business leaders and CFO Kuldeep Jain will participate.

Likely market impact

The call may help investors assess Q2 and H1 FY27 performance and management commentary. No new financial figures are disclosed.